Clinical Trials
33 trialsNCT01582191 2025-10-27
Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01586624 2021-10-07
A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1)
Cancer Research UK
Phase 1 Completed
NCT01183559 2021-01-22
A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery
Fox Chase Cancer Center
Phase 1 Completed
NCT00272350 2019-12-05
ZD6474 to Treat Advanced Brain Cancer in Patients
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00745732 2018-11-14
Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01539655 2017-05-02
Vandetanib
Sanofi
Phase 1 Completed
NCT00937417 2017-04-24
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
SWOG Cancer Research Network
Phase 1 Withdrawn
NCT00503711 2016-08-31
Phase I Chinese PK
Sanofi
Phase 1 Completed
NCT00450138 2016-08-29
Open Label, Phase I ZD6474 Head and Neck Cancer Study
Sanofi
Phase 1 Completed
NCT00681798 2016-08-29
Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma
Sanofi
Phase 1 Completed
NCT00807170 2016-08-29
Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases
Sanofi
Phase 1 Terminated
NCT00496275 2016-08-26
Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC
Sanofi
Phase 1 Completed
NCT00496509 2016-08-26
Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer
Sanofi
Phase 1 Completed
NCT00499850 2016-08-25
Phase I FOLFOX Combination
Sanofi
Phase 1 Completed
NCT00506051 2016-08-25
ZD6474(Vandetanib) + Alimta Combo Study
Sanofi
Phase 1 Completed
NCT00507091 2016-08-25
Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
Sanofi
Phase 1 Completed
NCT01941849 2015-12-21
VIBRaNT
University College, London
Phase 1 Withdrawn
NCT01004419 2015-10-02
Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer
University of Wisconsin, Madison
Phase 1 Withdrawn
NCT00821080 2015-05-01
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
Massachusetts General Hospital
Phase 1 Completed
NCT00996723 2015-04-06
Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
St. Jude Children's Research Hospital
Phase 1 Completed
NCT00601614 2014-03-10
Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Mayo Clinic
Phase 1 Withdrawn
NCT00660725 2014-01-23
Study of GemOx and Vandetanib in Advanced Solid Malignancy
University of Pittsburgh
Phase 1 Completed
NCT00551096 2013-12-25
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
University of Colorado, Denver
Phase 1 Completed
NCT00496665 2013-11-18
ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00822887 2013-06-26
IRUSZACT0073
University of Colorado, Denver
Phase 1 Completed
NCT00613223 2013-02-20
Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Duke University
Phase 1 Completed
NCT00613054 2012-12-05
Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
Duke University
Phase 1 Completed
NCT00472017 2012-10-15
Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma
St. Jude Children's Research Hospital
Phase 1 Completed
NCT00436072 2012-10-04
ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00532909 2012-07-16
Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
Stanford University
Phase 1 Completed
NCT00734890 2012-03-16
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00533169 2011-12-15
ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00732745 2011-08-22
Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction
Case Comprehensive Cancer Center
Phase 1 Terminated